Kairos Pharma Ltd. (KAPA)

1.06

0.12 (12.77%)

At close: Apr 04, 2025, 3:59 PM

1.07

0.58%

After-hours: Apr 04, 2025, 07:56 PM EDT

Kairos Pharma Ltd. Cash Flow Statement

Chart Mode

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net Income	-1.81M	-1.05M	-2.15M	-1.05M
Depreciation & Amortization	160K	160K	98K	n/a
Stock-Based Compensation	913K	n/a	300K	800K
Other Working Capital	764K	129K	1.19M	212.82K
Other Non-Cash Items	56K	408K	144K	n/a
Deferred Income Tax	n/a	n/a	n/a	n/a
Change in Working Capital	764K	129K	1.19M	212.82K
Operating Cash Flow	81K	-353K	-412K	-38.53K
Capital Expenditures	n/a	n/a	n/a	n/a
Acquisitions	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	-109K	n/a
Investing Cash Flow	n/a	n/a	-109K	n/a
Debt Repayment	n/a	895K	330K	50K
Common Stock Repurchased	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a
Other Financial Acitivies	-425K	-178K	n/a	-13K
Financial Cash Flow	-425K	717K	580K	37K
Net Cash Flow	-344K	364K	59K	-1.53K
Free Cash Flow	81K	-353K	-412K	-38.53K